Bank of America
PGNX

Bank of America’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bank of America’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-65,327
Closed -$248K – 7332
2020
Q1 		$248K Sell
65,327
-459,343
-88% -$1.98M ﹤0.01% 4962
2019
Q4 		$2.67M Buy
524,670
+288,390
+122% +$1.53M ﹤0.01% 3795
2019
Q3 		$1.2M Sell
236,280
-138,225
-37% -$689K ﹤0.01% 4426
2019
Q2 		$2.31M Sell
374,505
-322,303
-46% -$1.55M ﹤0.01% 3928
2019
Q1 		$3.23M Buy
696,808
+549,839
+374% +$2.49M ﹤0.01% 3580
2018
Q4 		$616K Sell
146,969
-82,212
-36% -$419K ﹤0.01% 4791
2018
Q3 		$1.44M Sell
229,181
-47,990
-17% -$369K ﹤0.01% 4228
2018
Q2 		$2.23M Sell
277,171
-118,099
-30% -$902K ﹤0.01% 3893
2018
Q1 		$2.95M Buy
395,270
+142,784
+57% +$949K ﹤0.01% 3562
2017
Q4 		$1.5M Sell
252,486
-330,698
-57% -$2.01M ﹤0.01% 4186
2017
Q3 		$4.29M Buy
583,184
+173,589
+42% +$1.1M ﹤0.01% 3326
2017
Q2 		$2.78M Buy
409,595
+26,415
+7% +$195K ﹤0.01% 3594
2017
Q1 		$3.62M Buy
383,180
+81,852
+27% +$817K ﹤0.01% 3337
2016
Q4 		$2.6M Buy
301,328
+291,343
+2,918% +$2.15M ﹤0.01% 3545
2016
Q3 		$64K Sell
9,985
-7,153
-42% -$43.2K ﹤0.01% 5639
2016
Q2 		$73K Buy
17,138
+10,138
+145% +$49K ﹤0.01% 5681
2016
Q1 		$31K Sell
7,000
-12,825
-65% -$57.1K ﹤0.01% 5964
2015
Q4 		$122K Sell
19,825
-6,837
-26% -$44.8K ﹤0.01% 5645
2015
Q3 		$152K Sell
26,662
-80,134
-75% -$615K ﹤0.01% 5480
2015
Q2 		$797K Buy
106,796
+75,780
+244% +$458K ﹤0.01% 4306
2015
Q1 		$186K Sell
31,016
-11,844
-28% -$74.5K ﹤0.01% 4970
2014
Q4 		$325K Sell
42,860
-23,518
-35% -$141K ﹤0.01% 4969
2014
Q3 		$344K Sell
66,378
-50,345
-43% -$251K ﹤0.01% 4921
2014
Q2 		$504K Sell
116,723
-18,944
-14% -$72.3K ﹤0.01% 4610
2014
Q1 		$554K Sell
135,667
-12,850
-9% -$65.7K ﹤0.01% 4499
2013
Q4 		$791K Buy
148,517
+33,543
+29% +$148K ﹤0.01% 4325
2013
Q3 		$577K Buy
114,974
+3,668
+3% +$19.9K ﹤0.01% 4490
2013
Q2 		$497K Buy
+111,306
New +$499K ﹤0.01% 4751

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Bank of America's PGNX Position: Q2 2020 in Review

Bank of America sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 65,327 shares — an estimated $248K sold.

Bank of America first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $4.29M in Q3 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Bank of America reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Bank of America sold 65,327 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $248K.
  • Bank of America first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
  • Bank of America's Progenics Pharmaceuticals Inc position peaked at $4.29M in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Bank of America's 13F filing for Q2 2020, filed 14 Aug 2020.